HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Haleema Shakur Selected Research

Antifibrinolytic Agents (Antifibrinolytics)

1/2020Antifibrinolytic drugs for treating primary postpartum hemorrhage.
1/2018Tranexamic acid for treatment of women with post-partum haemorrhage in Nigeria and Pakistan: a cost-effectiveness analysis of data from the WOMAN trial.
1/2018Effect of treatment delay on the effectiveness and safety of antifibrinolytics in acute severe haemorrhage: a meta-analysis of individual patient-level data from 40 138 bleeding patients.
1/2018Antifibrinolytic drugs for treating primary postpartum haemorrhage.
5/2015Antifibrinolytic drugs for acute traumatic injury.
1/2014Central and statistical data monitoring in the Clinical Randomisation of an Antifibrinolytic in Significant Haemorrhage (CRASH-2) trial.
1/2012Antifibrinolytic drugs for acute traumatic injury.
1/2011Antifibrinolytic drugs for acute traumatic injury.
4/2010The WOMAN Trial (World Maternal Antifibrinolytic Trial): tranexamic acid for the treatment of postpartum haemorrhage: an international randomised, double blind placebo controlled trial.
1/2010Haemostatic drugs for traumatic brain injury.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Haleema Shakur Research Topics

Disease

26Hemorrhage
05/2018 - 02/2005
19Wounds and Injuries (Trauma)
01/2018 - 12/2009
7Craniocerebral Trauma (Head Injury)
01/2018 - 10/2004
7Traumatic Brain Injuries (Traumatic Brain Injury)
01/2018 - 12/2009
3Pulmonary Embolism
01/2018 - 05/2012
3Myocardial Infarction
01/2018 - 05/2012
3Venous Thrombosis (Deep-Vein Thrombosis)
01/2018 - 05/2012
3Stroke (Strokes)
01/2018 - 05/2012
2Vomiting
02/2014 - 05/2011
2Coma (Comas)
03/2011 - 10/2004
2Virus Diseases (Viral Diseases)
02/2010 - 07/2009
1Postpartum Hemorrhage
01/2020
1Seizures (Absence Seizure)
01/2018
1Intracranial Thrombosis (Cerebral Thrombosis)
01/2017
1Thrombosis (Thrombus)
01/2017
1Renal Insufficiency (Renal Failure)
05/2015
1Shock
05/2015
1Pain (Aches)
05/2011
1Hypothermia
01/2011
1Surgical Blood Loss
04/2010
1Infections
02/2010
1Nausea
07/2009

Drug/Important Bio-Agent (IBA)

24Tranexamic Acid (AMCA)FDA Link
05/2018 - 07/2009
12Antifibrinolytic Agents (Antifibrinolytics)IBA
01/2020 - 02/2005
5Adrenal Cortex Hormones (Corticosteroids)IBA
05/2012 - 10/2004
2Aprotinin (Trasylol)FDA Link
05/2015 - 01/2010
2Misoprostol (Cytotec)FDA LinkGeneric
02/2014 - 05/2011
2MethylprednisoloneFDA LinkGeneric
06/2005 - 10/2004
1Pharmaceutical PreparationsIBA
01/2018
1Saline SolutionIBA
01/2011
1recombinant FVIIa (rFVIIa)FDA Link
01/2010
1Aminocaproic Acid (6 Aminocaproic Acid)FDA LinkGeneric
01/2010
1Factor VIIa (Activated Factor VII)IBA
01/2010
1LF 16-0687IBA
12/2009
1Bradykinin B2 ReceptorIBA
12/2009
1Peptides (Polypeptides)IBA
12/2009
1Fibrinolytic Agents (Antithrombotic Agents)IBA
07/2009

Therapy/Procedure

10Blood Transfusion (Blood Transfusions)
01/2018 - 07/2009
4Time-to-Treatment
01/2018 - 03/2011
3Critical Care (Surgical Intensive Care)
01/2018 - 01/2011
3Hysterectomy
01/2018 - 07/2009
1Braces
01/2018
1Laparotomy
01/2018
1Sutures (Suture)
01/2018
1Treatment Delay
01/2018
1Patient Transfer (Patient Dumping)
01/2015
1Induced Hypothermia
01/2011